LBPO.MCB01 · 分子与细胞生物学 · Late-Breaking
黏附型GPCR BAI3的一种新型短亚型源自替代启动子,可逆转EMT过程并在多形性胶质母细胞瘤(GBM)中带来生存获益
A novel short isoform of adhesion GPCR BAI3, originated from an alternative promoter, reverses the EMT process, and confers survival benefit in glioblastoma multiforme (GBM)
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
BAI3(ADGRB3基因)是黏附型G蛋白偶联受体的成员,主要在脑中表达,调控树突形态发生、突触可塑性等。在此,我们首次报告ADGRB3转录本在GBM中的存在、转录起源和功能意义。免疫印迹显示野生型小鼠中同时存在全长(FL-)和短(S-)BAI3亚型,而在外显子10靶向的BAI3敲除(KO)小鼠中仅检测到S-BAI3。相反,在外显子2和18靶向的BAI3 KO小鼠中两种亚型均不存在。长读长亚型测序独立证实了小鼠皮层中短转录本的存在。H3K4me3和H3K27ac ChIP-Seq在小鼠中鉴定出外显子1和18附近具有转录活性的启动子区域。与此一致,我们发现源自内含子17替代启动子的短转录本是人脑中最丰富的ADGRB3转录本。与FL-BAI3不同,S-BAI3优先定位于细胞内区室而非细胞膜。在GTEx-Brain和TCGA-GBM数据集中评估ADGRB3的转录本特异性表达,揭示了原发和复发GBM肿瘤中FL-和S-BAI3蛋白编码转录本均显著下调。对全基因组亚硫酸氢盐测序(GSE121721)的分析揭示了多个GBM特异性高甲基化区域,代表ADGRB3调控区域的表观遗传重塑。功能评估表明,S-BAI3过表达显著降低了LN229胶质母细胞瘤细胞系的增殖。任一亚型的过表达均导致伤口愈合显著延迟、细胞迁移和侵袭减少,其中S-BAI3的效应最强。为确定BAI3亚型抗肿瘤活性的分子机制,我们使用反相蛋白质阵列评估了450个蛋白质生物标志物的变化。两种亚型均抑制上皮-间质转化(EMT)特征并促进间质-上皮转变,其中S-BAI3效应最强。TCGA-GBM和GTEx-Brain的比较分析显示出相似的模式,将EMT与BAI3亚型的表达联系起来。为阐明BAI3亚型的体内效应,将裸鼠原位接种表达IRFP720的空载体对照、FL-和S-BAI3过表达的LN229细胞。归一化IRFP720信号的纵向分析显示,与对照相比,两种亚型均显著减弱肿瘤生长,这与光片显微镜的3D肿瘤成像一致。生存分析表明,S-BAI3过表达组的中位生存期显著增加(72.5天;HR=0.25,P=0.007),而FL-BAI3过表达未带来生存获益。综上所述,我们的结果提示BAI3亚型在GBM中被表观遗传沉默,而替代启动子驱动的S-BAI3是一种机制上独特的肿瘤抑制因子,对GBM中亚型特异性的表观遗传重新激活和治疗靶向具有直接意义。
查看英文原文 English abstract
BAI3 (ADGRB3 gene), a member of the adhesion G-protein-coupled receptors, is predominantly expressed in the brain and regulates dendritic morphogenesis, synaptic plasticity, etc. Here, we report for the first time the existence, transcriptional origin, and functional significance of ADGRB3 transcripts in GBM.Immunoblotting revealed both Full-length (FL-) and short (S-) BAI3 isoforms in wild-type mice, whereas only S-BAI3 was detected in exon 10-targeted BAI3 knockout (KO) mice. In contrast, neither isoform is present in exon 2 and 18-targeted BAI3 KO mice. Long-read isoform sequencing independently confirmed the presence of short transcripts in mice cortex. H3K4me3 and H3K27ac ChIP-Seq identified transcriptionally active promoter regions near exons 1 and 18 in mice. Consistently, we found that the short transcript, originating from alternative promoter in intron 17, is the most abundant ADGRB3 transcript in the human brain. Unlike FL-BAI3, S-BAI3 is preferentially localized to intracellular compartments rather than the cell membraneEvaluation of the transcripts-specific expression of ADGRB3 in GTEx-Brain and TCGA-GBM dataset revealed significant downregulation of both FL- and S-BAI3 protein-encoding transcripts in primary and recurrent GBM tumors. Analysis of whole-genome bisulfite sequencing (GSE121721) revealed multiple GBM-specific hypermethylated regions, representing epigenetic remodeling of regulatory regions of ADGRB3. Functional evaluation demonstrated that S-BAI3 overexpression significantly reduced the proliferation of LN229 glioblastoma cell lines. Overexpression of either isoform resulted in significantly delayed wound closure, reduced cell migration and invasion, with the strongest effects observed for S-BAI3. To determine the molecular mechanism of the antitumor activity of BAI3 isoforms, we assessed the alteration of 450 protein biomarkers by using a reverse-phase protein array. Both isoforms suppress epithelial-to-mesenchymal transition (EMT) signature and promote mesenchymal-to-epithelial shift, S-BAI3 exerting the strongest effect. Comparative analysis of TCGA-GBM and GTEx-Brain demonstrated similar patterns, linking EMT to the expression of BAI3 isoforms. To illustrate the in vivo effect of BAI3 isoforms, nude mice were orthotopically inoculated with IRFP720-expressing empty vector control, FL- and S-BAI3 overexpressing LN229 cells. Longitudinal analysis of the normalized IRFP720 signal revealed that both isoforms significantly attenuated tumor growth compared to the control, consistent with 3D tumor imaging by light sheet microscopy. Survival analysis demonstrated a significant increase in the median survival in the S-BAI3 overexpressing group (72.5 days; HR=0.25, P=0.007), whereas the FL-BAI3 overexpression did not confer survival benefit.Taken together, our results suggest that BAI3 isoforms are epigenetically silenced in GBM, and alternative promoter-driven S-BAI3 is a mechanistically distinct tumor-suppressor with direct implications for isoform-specific epigenetic reactivation and therapeutic targeting in GBM.
利益披露 Disclosure
R. Parag, None..
V. Farias, None..
H. A. Alsharif, None..
M. Bhuiya, None..
J. Stillwell, None..
Y. Kuranaga, None..
M. Elmi, None..
N. Hama, None..
M. Kamata, None..
S. Bhatnagar, None..
E. G. Van Meir, None.